A rating of 94 puts Agile Therapeutics Inc (AGRX) near the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. Agile Therapeutics Inc's score of 94 means it scores higher than 94% of stocks in the industry. Agile Therapeutics Inc also received an overall rating of 63, putting it above 63% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 132 out of the 148 industries.
What do These Ratings Mean?
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 63 would rank higher than 63 percent of all stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Agile Therapeutics Inc Stock Today?
Agile Therapeutics Inc (AGRX) stock has fallen -0.79% while the S&P 500 has risen 0.15% as of 1:58 PM on Monday, Dec 14. AGRX has fallen -$0.02 from the previous closing price of $2.91 on volume of 690,055 shares. Over the past year the S&P 500 has gained 14.96% while AGRX has risen 36.32%. AGRX lost -$0.50 per share the over the last 12 months.